ScholarIQanswers from OpenAlex
Botulinum Toxin and Related Neurological Disorders
TopicLeading institutions, researchers & key papers
Botulinum Toxin and Related Neurological Disorders is a topic indexed in ScholarIQ from OpenAlex.
What is known about Botulinum Toxin and Related Neurological Disorders?
ScholarIQrecord summary
This cluster of papers focuses on the use of Botulinum Toxin in neurology and medicine, particularly in the treatment of spasticity, stroke-related complications, pain management, and neurological disorders. It covers topics such as the mechanism of action, protein receptors, toxicology, and the clinical application of Botulinum Toxin.
How many works does Botulinum Toxin and Related Neurological Disorders have?
ScholarIQindexed works
Botulinum Toxin and Related Neurological Disorders has 306 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Botulinum Toxin and Related Neurological Disorders?
ScholarIQopenalex
The OpenAlex for Botulinum Toxin and Related Neurological Disorders is on the source record.
What are the most-cited papers on Botulinum Toxin and Related Neurological Disorders?
ScholarIQmost cited works
Spasticity After Stroke
Disa K. Sommerfeld, Elsy Eek, Anna-Karin Svensson, Lotta Widén Holmqvist, Magnus von Arbin
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
Alena Novotná, Jan Mareš, S. Ratcliffe, Iveta Nováková, Marta Vachová, Olga Zapletalová, Claudio Gasperini, Carlo Pozzilli, Luca Ausili Cefaro, Giancarlo Comi, Paolo Rossi, Zdeněk Ambler, Z Stelmasiak, Alf-Peter Erdmann, Xavier Montalbán, A Klimek, Paul Davies, the Sativex Spasticity Study Group
Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study
Robert J. Coffey, David W. Cahill, William D. Steers, T. S. Park, Joe Ordia, Jay M. Meythaler, Richard Herman, Andrew G. Shetter, Robert M. Levy, Brian Gill, Richard Smith, Jack E. Wilberger, John D. Loeser, Charles Chabal, Claudio A. Feler, James T. Robertson, Richard D. Penn, Aiden Clarke, Kim J. Burchiel, Lyal G. Leibrock
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy
H. Kerr Graham, K. Roger Aoki, Ilona Autti‐Rämö, Roslyn N. Boyd, Mauricio R. Delgado, Deborah Gaebler‐Spira, Mark Gormley, Barry M. Guyer, Florian Heinen, Andrew Holton, Dennis J. Matthews, Guy Molenaers, Francesco Motta, Pedro Ruiz, Jörg Wissel
Pathophysiology of Spasticity: Implications for Neurorehabilitation
Carlo Trompetto, Lucio Marinelli, Laura Mori, Elisa Pelosin, Antonio Currà, Luigi Molfetta, Giovanni Abbruzzese
Where is Botulinum Toxin and Related Neurological Disorders research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Botulinum Toxin and Related Neurological Disorders is open access?
ScholarIQopen access share
60%OPEN ACCESS